Business Description
TransMedics Group Inc
NAICS : 334510
SIC : 3845
ISIN : US89377M1099
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 2.47 | |||||
Debt-to-EBITDA | 8 | |||||
Interest Coverage | 2.18 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.39 | |||||
Beneish M-Score | -1.77 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 92.7 | |||||
3-Year EBITDA Growth Rate | 36.8 | |||||
3-Year EPS without NRI Growth Rate | 12.4 | |||||
3-Year FCF Growth Rate | -68.1 | |||||
3-Year Book Growth Rate | 3.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 40.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 8.8 | |||||
9-Day RSI | 12.9 | |||||
14-Day RSI | 18.04 | |||||
6-1 Month Momentum % | 66.79 | |||||
12-1 Month Momentum % | 318.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.2 | |||||
Quick Ratio | 7.33 | |||||
Cash Ratio | 5.5 | |||||
Days Inventory | 104.27 | |||||
Days Sales Outstanding | 68.7 | |||||
Days Payable | 27.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -8.19 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.34 | |||||
Operating Margin % | 7.84 | |||||
Net Margin % | 8.14 | |||||
FCF Margin % | -30.05 | |||||
ROE % | 19.83 | |||||
ROA % | 4.45 | |||||
ROIC % | 10.14 | |||||
3-Year ROIIC % | -0.22 | |||||
ROC (Joel Greenblatt) % | 16.05 | |||||
ROCE % | 6.94 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 87.2 | |||||
Forward PE Ratio | 49.68 | |||||
PE Ratio without NRI | 89.78 | |||||
PEG Ratio | 3.9 | |||||
PS Ratio | 7.64 | |||||
PB Ratio | 13.09 | |||||
Price-to-Tangible-Book | 14.01 | |||||
Price-to-Operating-Cash-Flow | 121.69 | |||||
EV-to-EBIT | 62.39 | |||||
EV-to-EBITDA | 45.36 | |||||
EV-to-Revenue | 7.33 | |||||
EV-to-Forward-Revenue | 5.36 | |||||
EV-to-FCF | -24.38 | |||||
Price-to-Graham-Number | 7.48 | |||||
Earnings Yield (Greenblatt) % | 1.6 | |||||
FCF Yield % | -4.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TMDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TransMedics Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 401.09 | ||
EPS (TTM) ($) | 0.94 | ||
Beta | 2.07 | ||
Volatility % | 118.12 | ||
14-Day RSI | 18.04 | ||
14-Day ATR ($) | 8.82961 | ||
20-Day SMA ($) | 126.15025 | ||
12-1 Month Momentum % | 318.89 | ||
52-Week Range ($) | 38.13 - 177.37 | ||
Shares Outstanding (Mil) | 33.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TransMedics Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TransMedics Group Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
TransMedics Group Inc Frequently Asked Questions
What is TransMedics Group Inc(TMDX)'s stock price today?
When is next earnings date of TransMedics Group Inc(TMDX)?
Does TransMedics Group Inc(TMDX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |